Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scheduled Post-operative Medication After Cesarean
NCT04612920Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Dec 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen and acetaminophen in postoperative pain (2 arms), sponsored by University of Oklahoma. Primary endpoints: Morphine Milligram Equivalents used from 25-72 hours post-op and Morphine Milligram Equivalents usage from discharge to outpatient visit. Started Dec 2020; status: completed.
02
Drugs
ibuprofenacetaminophen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04612920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04612920.